OSPAR CONVENTION FOR THE PROTECTION OF THE MARINE ENVIRONMENT OF THE NORTH-EAST ATLANTIC
OSPAR List of Chemicals for Priority Action (Up-date 2002) OSPAR List of Chemicals for Priority Action (Up-date 2002) Type Group of substances / substances EINECS No Identified at †: Lead country: Background document A: CHEMICALS WHERE A BACKGROUND DOCUMENT HAS BEEN OR IS BEING PREPARED 4-tert-butyltoluene lead and organic lead compounds mercury and organic mercury compounds
OSPAR/MMC 1998: United Kingdom: Published 2000 (ISBN: 0 946956 54 5)
organic tin compounds
OSPAR/MMC 1998: The Netherlands: Published 2000 (ISBN: 0 946956 561) addressing TBT and TPT
neodecanoic acid, ethenyl ester tetrabromobisphenol A (TBBP-A) hexachlorocyclopentadiene (HCCP) 1,2,3-trichlorobenzene 1,2,4-trichlorobenzene 1,3,5-trichlorobenzene brominated flame retardants
OSPAR/MMC 1998: Sweden: Published in 2001 (ISBN: 0 946956 70 7) addressing: polybrominated diphenylethers; polybrominated biphenyls; hexabromocyclo-dodecane
polychlorinated biphenyls (PCBs)
OSPAR/MMC 1998: Germany & Belgium: Published 2001 (ISBN: 0 946956 78 2)
polychlorinated dibenzodioxins (PCDDs) polychlorinated dibenzofurans (PCDFs) short chained chlorinated paraffins (SCCP)
OSPAR/MMC 1998: Sweden: Published 2001 (ISBN: 0 946956 77 4)
4-(dimethylbutylamino)diphenylamin triphenyl phosphine hexamethyldisiloxane (HMDS) Type Group of substances / substances EINECS No Identified at †: Lead country: Background document Pesticides/Biocides/Organohalogens dicofol endosulphan hexachlorocyclohexane isomers (HCH) methoxychlor pentachlorophenol (PCP)
OSPAR/MMC 1998: Finland: Published 2001 (ISBN: 0 946956 74 X)
trifluralin clotrimazole 2,4,6-tri-tert-butylphenol nonylphenol/ethoxylates (NP/NPEs) and
OSPAR/MMC 1998: Sweden: Published 2001(ISBN: 0 946956 79 0)
related substances octylphenol certain phthalates: dibutylphthalate,
OSPAR/MMC 1998: Denmark & Francediethylhexylphthalate polyaromatic hydrocarbons (PAHs)
OSPAR/MMC 1998: Norway: Published 2001 (ISBN: 0 946956 73 X)
musk xylene
OSPAR/MMC 1998: Switzerland: Published 2000 (ISBN: 0 946956 55 3) addressing musk xylene, musk ketone, moskene and musk tibetene
B:CHEMICALS WHERE NO BACKGROUND DOCUMENT IS BEING PREPARED BECAUSE THEY ARE INTERMEDIATES IN CLOSED SYSTEMS 1,5,9 cyclododecatriene cyclododecane C: CHEMICALS WHERE NO BACKGROUND DOCUMENT IS BEING PREPARED BECAUSE THERE IS NO CURRENT PRODUCTION OR USE INTEREST* 2,4,6-bromophenyl 1-2(2,3-dibromo-2- methylpropyl) * pentabromoethylbenzene* heptachloronorbornene* pentachloroanisole* polychlorinated naphthalenes*, Type Group of substances / substances EINECS No Identified at †: Lead country: Background document 3,3'-(ureylenedimethylene)bis(3,5,5- trimethylcyclohexyl) diisocyanate* ethyl O-(p-nitrophenyl) phenyl phosphonothionate (EPN)* flucythrinate* isodrin* tetrasul* diosgenin* Endnotes
The substances in this list were identified at the following OSPAR Commission meetings:
OSPAR/MMC 1998: Agreement reference number 1998-16 (Annex 2 to the OSPAR Strategy with regard to Hazardous Substances);
When identifying the substances or groups of substances, OSPAR/MMC 1998 has not allocated CAS and EINECS registration numbers. Background documents adopted by the OSPAR Commission for these substances or groups of substances may indicate which substances have been addressed so far by OSPAR)
OSPAR 2000: Agreement reference number 2000-10;
OSPAR 2001: Agreement reference number 2001-2;
OSPAR 2002: Agreement reference number 2002-18
The identification of these substances and the consequent action required is explained in § 7.6 of the OSPAR 2002 Summary Record. In brief, these substances have rankings in terms of persistency, liability to bioaccumulate and toxicity which are of equal concern as the other substances on this list. However, to the best of OSPAR’s knowledge, on the basis of information from industry, OSPAR accepts that this substance is produced and used exclusively as an intermediate in closed systems in the production of other substances, under conditions where the safeguards applying are sufficient to avoid reasonable concerns that discharges, emissions or losses of the substance could reach the marine environment. Therefore, every five years, commencing in 2003, Contracting Parties and, where appropriate, observers representing the chemicals industries should report to OSPAR:
whether they have found any evidence that these chemicals are being produced, used or discharged without being subjected to safeguards to avoid reasonable concerns that discharges, emissions or losses of the substances could reach the marine environment, and, if so, what that evidence is, and what action (if any) has been taken;
whether there have been any cases where applications have been made for approvals involv ing these chemicals, and, if so, what decision was taken.
The identification of these substances and the consequent action required is explained in § 4.13 of the OSPAR 2001 Summary Record. In brief, these substances have rankings in terms of persistency, liability to bioaccumulate and toxicity which are of equal concern as the other substances on this list. However, to the best of OSPAR’s knowledge, there is no current production or use in the OSPAR states. Therefore, every five years, commencing in 2003, Contracting Parties and, where appropriate, observers representing the chemicals industries should report to OSPAR:
whether they have found any evidence that these chemicals are being produced, used or discharged, and, if so, what that evidence is, and what action (if any) has been taken;
whether there have been any cases where applications have been made for approvals involving these chemicals, and, if so, what decision was taken.
These substances have currently no lead country to further the work within OSPAR and will have to be considered at a later date.
Polychlorinated naphthalenes should be treated as a group of substances (OSPAR 02/21/1, § 7.7).
This article is reprinted here for the benefit of our clients and their families. We recommend that all of our clients read this article and pass it on to family and friends. Reprinted Article for educational purposes from the New England Journal of Medicine Recently Senator Charles Grassley, ranking Republican on the Senate Finance Committee, has been looking into financial ties between the
25 Hydroxy Vitamin D This information is provided for informational purposes only and is not intended to diagnosis, treat, cure, or prevent disease. Abnormal test values falling outside the Normal Range will be printed in bold and noted in the “Flag” column. Abnormal values should be reviewed by your primary physician and a copy of all testing should be included in your medical re